Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 30 | $17,049,446 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Nov 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | President | 12 Nov 2024 | Sale | 15,105 | 88.72 | 1,340,116 | D |
| 14 Nov 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | President | 12 Nov 2024 | Sale | 6,116 | 89.63 | 548,177 | D |
| 14 Nov 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | President | 12 Nov 2024 | Sale | 1,648 | 90.89 | 149,787 | D |
| 14 Nov 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | President | 13 Nov 2024 | Sale | 13,371 | 88.17 | 1,178,921 | D |
| 14 Nov 2024 18:01 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | President | 13 Nov 2024 | Sale | 5,343 | 88.92 | 475,100 | D |
| 11 Mar 2024 20:32 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 11 Mar 2024 | Sale | 1,238 | 66.7 | 82,575 | D |
| 11 Mar 2024 20:32 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 11 Mar 2024 | Sale | 6,107 | 65.82 | 401,963 | D |
| 11 Mar 2024 20:32 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 07 Mar 2024 | Sale | 220 | 66.81 | 14,698 | D |
| 11 Mar 2024 20:32 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 07 Mar 2024 | Sale | 12,912 | 66.14 | 854,000 | D |
| 27 Feb 2024 20:00 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 26 Feb 2024 | Sale | 392 | 70.13 | 27,491 | D |
| 27 Feb 2024 20:00 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 26 Feb 2024 | Sale | 7,215 | 69.54 | 501,731 | D |
| 27 Feb 2024 20:00 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 26 Feb 2024 | Sale | 300 | 68.54 | 20,562 | D |
| 05 Feb 2024 18:13 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 02 Feb 2024 | Sale | 714 | 67.17 | 47,959 | D |
| 05 Feb 2024 18:13 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 02 Feb 2024 | Sale | 11,146 | 66.37 | 739,760 | D |
| 12 Jan 2024 18:02 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 11 Jan 2024 | Sale | 1,486 | 67.8 | 100,751 | D |
| 12 Jan 2024 18:02 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 11 Jan 2024 | Sale | 30,360 | 67.1 | 2,037,156 | D |
| 12 Jan 2024 18:02 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 11 Jan 2024 | Sale | 18,154 | 66.31 | 1,203,792 | D |
| 14 Nov 2023 17:33 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 13 Nov 2023 | Sale | 8,933 | 53.37 | 476,754 | D |
| 14 Nov 2023 17:33 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 13 Nov 2023 | Sale | 41,067 | 54.01 | 2,218,029 | D |
| 13 Mar 2023 19:34 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 13 Mar 2023 | Sale | 476 | 44.15 | 21,015 | D |
| 13 Mar 2023 19:34 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 13 Mar 2023 | Sale | 6,868 | 44.99 | 308,991 | D |
| 13 Mar 2023 19:34 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 10 Mar 2023 | Sale | 2,500 | 42.52 | 106,300 | D |
| 13 Mar 2023 19:34 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 10 Mar 2023 | Sale | 14,208 | 43.2 | 613,786 | D |
| 27 Feb 2023 20:01 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 24 Feb 2023 | Sale | 7,906 | 47.03 | 371,819 | D |
| 22 Feb 2023 20:03 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 21 Feb 2023 | Sale | 100 | 49.6 | 4,960 | D |
| 22 Feb 2023 20:03 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 21 Feb 2023 | Sale | 1,100 | 48.68 | 53,548 | D |
| 22 Feb 2023 20:03 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 21 Feb 2023 | Sale | 643 | 47.23 | 30,369 | D |
| 22 Feb 2023 20:03 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 21 Feb 2023 | Sale | 9,296 | 46.56 | 432,822 | D |
| 02 Dec 2022 19:14 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 01 Dec 2022 | Sale | 22,796 | 53.48 | 1,219,130 | D |
| 02 Dec 2022 19:14 | ITCI | Intra-Cellular Therapies Inc | HALSTEAD MICHAEL | EVP and General Counsel | 01 Dec 2022 | Sale | 27,204 | 53.94 | 1,467,384 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)